File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation

TitleComparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation
Authors
Lau, CYTorre, COMan, KCKStewart, HMSeager, SVan Zandt, MReich, CLi, JBrewster, JLip, GYHHingorani, ADWei, LWong, ICK
Issue Date2022
Citation
Annals of Internal Medicine, 2022, v. 175, p. 1515-1524 How to Cite?
DOI: http://dx.doi.org/10.7326/M22-0511
Persistent Identifierhttp://hdl.handle.net/10722/323216
ISI Accession Number ID
WOS:000906286000022

 

DC FieldValueLanguage
dc.contributor.authorLau, CY-
dc.contributor.authorTorre, CO-
dc.contributor.authorMan, KCK-
dc.contributor.authorStewart, HM-
dc.contributor.authorSeager, S-
dc.contributor.authorVan Zandt, M-
dc.contributor.authorReich, C-
dc.contributor.authorLi, J-
dc.contributor.authorBrewster, J-
dc.contributor.authorLip, GYH-
dc.contributor.authorHingorani, AD-
dc.contributor.authorWei, L-
dc.contributor.authorWong, ICK-
dc.date.accessioned2022-12-02T14:05:46Z-
dc.date.available2022-12-02T14:05:46Z-
dc.date.issued2022-
dc.identifier.citationAnnals of Internal Medicine, 2022, v. 175, p. 1515-1524-
dc.identifier.urihttp://hdl.handle.net/10722/323216-
dc.languageeng-
dc.relation.ispartofAnnals of Internal Medicine-
dc.titleComparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation-
dc.typeArticle-
dc.identifier.emailWong, ICK: wongick@hku.hk-
dc.identifier.authorityWong, ICK=rp01480-
dc.identifier.doi10.7326/M22-0511-
dc.identifier.hkuros342662-
dc.identifier.volume175-
dc.identifier.spage1515-
dc.identifier.epage1524-
dc.identifier.isiWOS:000906286000022-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats